Skip to main navigation
Nektar Therapeutics
  • About Nektar
    • Our Story
    • Leadership
    • Partnering for Innovation
    • Contact Us
  • Our Pipeline
    • Pipeline
    • Clinical Trials
  • Our Science
    • Scientific Approach
    • Scientific Publications
  • Investors
    • Investor Overview
    • Financials & Filings
    • Press Releases
    • SEC Filings
    • Investor Events
    • Corporate Governance
    • Stock Information
    • Contact IR
    • Historic Stock Lookup
    • Email Alerts
    • Analyst Coverage
  • Our Culture
    • Careers at Nektar
  • For Patients
  • linkedin
Nektar Therapeutics
  • About Nektar
    • Our Story
    • Leadership
    • Partnering for Innovation
    • Contact Us
  • Our Pipeline
    • Pipeline
    • Clinical Trials
  • Our Science
    • Scientific Approach
    • Scientific Publications
  • Investors
    • Investor Overview
    • Financials & Filings
    • Press Releases
    • SEC Filings
    • Investor Events
    • Corporate Governance
    • Stock Information
    • Contact IR
    • Historic Stock Lookup
    • Email Alerts
    • Analyst Coverage
  • Our Culture
    • Careers at Nektar
  • For Patients
  • linkedin
investor relations hero

SEC filing details

Document Details

Form
4
Filing Date
Nov 25, 2025
Document Date
Nov 21, 2025
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Nektar Therapeutics
Issuer
NEKTAR THERAPEUTICS
Filer
Zalevsky Jonathan

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Contact IR
Print Page
RSS
Email Alerts
Nektar Therapeutics
  • About Nektar
  • Our Pipeline
  • Our Science
  • Investors
  • Our Culture
  • For Patients
  • linkedin

©2026 Nektar Therapeutics

  • Privacy Policy
  • Terms of Use